TaiGen Biopharmaceuticals Holdings Ltd (太景醫藥研發控股) swung into profit last year with net profit of NT$775 million (US$27.1 million) after it received a bonus payment from China’s Zhejiang Medicine Co (浙江醫藥集團), it said yesterday.
Last year marked TaiGen’s first profitable year since 2017, as it registered net losses of NT$343 million in 2018, NT$295 million in 2019 and NT$404 million in 2020.
Despite reporting earnings per share of NT$1.08 for last year, the company’s board of directors has proposed not to distribute a cash dividend this year, TaiGen said.
The company attributed the improvement in its balance sheet to a payment of NT$1.29 billion from Zhejiang Medicine to buy TaiGen’s Chinese patent of its antibacterial drug Taigenxyn (nemonoxacin).
The money was used to develop the new experimental anti-influenza drug TG-1000 and a new antibiotic for a drug-resistant bacterium, the company said in a statement.
“We are still compiling the data generated in our phase 2 clinical trials for TG-1000, so it will take a while before we reveal the results,” TaiGen chairman Philip Huang (黃國龍) said in the statement.
TaiGen finished recruiting all 202 participants for human tests last month.
The company would determine the overseas market for the development of TG-1000 after phase 2 human trials are completed, Huang said.
Although the phase 2 tests are being conducted in China, the test results can be used to file an application with the US Food and Drug Administration, as the protocols of the tests meet the agency’s requirements, Huang said earlier this year.
The Eurovision Song Contest has seen a surge in punter interest at the bookmakers, becoming a major betting event, experts said ahead of last night’s giant glamfest in Basel. “Eurovision has quietly become one of the biggest betting events of the year,” said Tomi Huttunen, senior manager of the Online Computer Finland (OCS) betting and casino platform. Betting sites have long been used to gauge which way voters might be leaning ahead of the world’s biggest televised live music event. However, bookmakers highlight a huge increase in engagement in recent years — and this year in particular. “We’ve already passed 2023’s total activity and
BIG BUCKS: Chairman Wei is expected to receive NT$34.12 million on a proposed NT$5 cash dividend plan, while the National Development Fund would get NT$8.27 billion Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday announced that its board of directors approved US$15.25 billion in capital appropriations for long-term expansion to meet growing demand. The funds are to be used for installing advanced technology and packaging capacity, expanding mature and specialty technology, and constructing fabs with facility systems, TSMC said in a statement. The board also approved a proposal to distribute a NT$5 cash dividend per share, based on first-quarter earnings per share of NT$13.94, it said. That surpasses the NT$4.50 dividend for the fourth quarter of last year. TSMC has said that while it is eager
‘IMMENSE SWAY’: The top 50 companies, based on market cap, shape everything from technology to consumer trends, advisory firm Visual Capitalist said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) was ranked the 10th-most valuable company globally this year, market information advisory firm Visual Capitalist said. TSMC sat on a market cap of about US$915 billion as of Monday last week, making it the 10th-most valuable company in the world and No. 1 in Asia, the publisher said in its “50 Most Valuable Companies in the World” list. Visual Capitalist described TSMC as the world’s largest dedicated semiconductor foundry operator that rolls out chips for major tech names such as US consumer electronics brand Apple Inc, and artificial intelligence (AI) chip designers Nvidia Corp and Advanced
Pegatron Corp (和碩), an iPhone assembler for Apple Inc, is to spend NT$5.64 billion (US$186.82 million) to acquire HTC Corp’s (宏達電) factories in Taoyuan and invest NT$578.57 million in its India subsidiary to expand manufacturing capacity, after its board approved the plans on Wednesday. The Taoyuan factories would expand production of consumer electronics, and communication and computing devices, while the India investment would boost production of communications devices and possibly automotive electronics later, a Pegatron official told the Taipei Times by telephone yesterday. Pegatron expects to complete the Taoyuan factory transaction in the third quarter, said the official, who declined to be
RSS